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“Physical findings suggestive of the ventricle primarily involved in cardiogenic shock. Often pro-inflammatory states induced
by shock physiology causes a blunted performance of the less affected side. Both sides often contribute to the clinical 
presentation and physical exam findings” (Vahdatpour et	al.,	2019,	p.	3). Conclusion
• Because	of	the	viscous	cycle	that	
occurs	with	CS,	the	pathophysiology	
is	significant.
• In	normal	physiology	there	is	an	
equal	balance	between	the	right	and	
left	sides	of	the	heart.	The	amount	of	
blood	ejected	over	one	minute	or	
cardiac	output	is	the	same.
• In	cardiogenic	shock,	this	balance	is	
disrupted	leading	to	the	backup	of	
blood	into	the	lungs	and	periphery.	
• The	poor	systolic	function	of	the	left	
ventricle	in	patients	with	
cardiogenic	shock	leads	to	a	
downward	spiral	of	compensatory	
mechanisms	within	the	body.
Significance of Pathophysiology
• The	poor	compensatory	mechanisms	
are	significant	and	require	medical	
intervention.
• “Compensatory	peripheral	
vasoconstriction	may	initially	improve	
coronary	and	peripheral	perfusion,
however	it	contributes	to	increased	
cardiac	afterload	that	overburdens	
damaged	myocardium.	This	results	in	
diminished	oxygenated	blood	flow	to	
peripheral	tissue	and,	ultimately,	the	
heart”	(Vahdatpour et	al.,	2019,	p.	1).
• The	main	treatment	for	CS	is	identifying	the	underlying	cause	and	reversing	or	
treating	the	underlying	cause	if	possible.	
• Mechanical	support	devices	which	help	to	maintain	adequate	cardiac	output	and	
help	decrease	the	workload	of	the	heart.	Examples	include:
• Intra-aortic	balloon	pumps
• Extracorporeal	membrane	oxygenation	(ECMO)
• Impella devices
(den	Uil et	al.,	2017)
• Intravenous	fluids	with	a	goal	of	maintaining	a	euvolemic	status	(Kataja &	Harjola,	
2017).	
• Vasoactive	medications	with	the	goal	of	restoring	adequate	blood	pressure	and	
end-organ	perfusion	(Vahdatpour et	al.,	2019).
• Hemodynamic	monitoring	of	cardiac	output,	stroke	volume,	blood	pressure,	CVP,	
PCWP
• Echocardiogram	
Treatment
• Most	often,	patients	with	cardiogenic	shock	require	
admission	to	the	intensive	care	unit.	
• With	mechanical	support	devices	such	as	intra-aortic	
balloon	pumps	or	ECMO,	these	patients	require	
diligent	care	and	a	heightened	level	of	awareness.		
• Understanding	the	signs,	symptoms	and	
pathophysiology	behind	this	disease	process	is	
crucial	for	nurses	and	other	health	care	professionals	
to	be	able	to	adequately	care	for	such	patients.	
• The	ability	to	recognize	signs	of	CS	can	help	aid	in	
prompt	diagnosis	and	treatment.
• Advanced	knowledge	of	hemodynamic	parameters	
and	the	subtle	changes	of	each	parameter	is	an	
important	skill	to	have	and	crucial	while	caring	for	
cardiogenic	shock	patients.	
Cardiogenic	shock	presents	with	a	variety	
of	signs	and	symptoms.	Each	patient	is	
unique	in	their	presentation,	but	
generally	all	patients	with	cardiogenic	
shock	present	in	a	similar	manner.	As	a	
result	of	a	poorly	functioning	ventricle,	an	
inadequate	amount	of	blood	is	supplied	
to	the	tissues	and	patients	experience	
significant	hemodynamic	compromise.	
Both	physical	examination,	and	
hemodynamic	monitoring	parameters/	
monitoring	techniques	can	be	used	to	
evaluate	patients	(Mebazaa et	al.,	2018).
The	most	common	symptoms	include	the	
following:
• Tachycardia
• Hypotension
• Low	cardiac	output/	index
• Elevated	central	venous	pressure	
(CVP)
• Elevated	pulmonary	capillary	wedge	
pressure	(PCWP)
• Cool	extremities
• Weak	pulse
• Tachypnea
• Shortness	of	breath
• Confusion
• Elevated	lactate
• Low	pH
• Peripheral	edema
• Jugular	venous	distension
• Low	urine	output
(Vahdatpour et	al.,	2019)	
(Vahdatpour et	al.,	2019,	p.	8)
• Despite	significant	knowledge	and	understanding	of	
cardiovascular	physiology	and	the	pathophysiology	of	
cardiogenic	shock,	mortality	rates	remain	as	high	as	
35-50%	(Kataja &	Harjola,	2017).	
• Advanced	knowledge	of	the	treatment	modalities,	and	
pathophysiology	of	cardiogenic	shock	could	help	aid	in	
the	reduction	of	mortality	rates.
• Vigilant	nurses	who	can	identify	deteriorating	patients	
and	understand	the	pathophysiology	of	CS	can	notify	
necessary	healthcare	professionals	and	help	improve	
patient	outcomes.			
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